遗传性癫痫的定量脑电图生物标志物及其与神经结局的关联
本研究回顾性分析儿童医院临床脑电图,提取频谱特征,比较STXBP1、SCN1A、SYNGAP1相关癫痫与对照的定量脑电图差异,并训练随机森林模型预测诊断、癫痫频率和运动功能。结果显示STXBP1组α-δ功率比显著低于对照,模型能准确预测三种遗传癫痫诊断,但无法预测癫痫频率,运动评分预测优于年龄基线模型。
要点
- STXBP1相关癫痫患者α-δ功率比显著低于对照(中位Cohen d=-0.95,p<0.001)。
- 随机森林模型能准确区分STXBP1(AUC=0.92)、SYNGAP1(AUC=0.86)和SCN1A(AUC=0.85)与对照。
- 模型无法预测癫痫频率(AUC=0.53),但运动评分预测显著优于年龄基线模型(p<0.001)。
核心结论
- 部分遗传性癫痫及功能结局具有独特的定量脑电图特征,频谱特征可预测某些功能结局。
研究设计与样本
- 回顾性收集儿童医院临床头皮脑电图,去除伪迹和噪声后提取频谱特征,验证预处理流程,并训练随机森林模型。
主要发现
- STXBP1相关癫痫患者α-δ功率比显著低于对照(中位Cohen d=-0.95,p<0.001)。
- 模型预测STXBP1的AUC=0.92,SYNGAP1的AUC=0.86,SCN1A的AUC=0.85,相互区分准确率0.74。
- 模型无法预测癫痫频率(AUC=0.53),但运动评分预测显著优于年龄基线模型(p<0.001)。
- 自动计算的PDR与临床脑电图报告注释高度一致(R2=0.75)。
关键数值与推荐
- STXBP1组95份脑电图(n=20,40%女性,平均年龄3.98岁),SCN1A组154份(n=68,51%女性,平均年龄6.24岁),SYNGAP1组46份(n=21,57%女性,平均年龄6.97岁),对照847份(n=806,55%女性,平均年龄7.08岁)。
临床怎么用
- 定量脑电图频谱特征可作为遗传性癫痫的辅助生物标志物,用于诊断分类和运动功能评估。
- 大规模回顾性定量分析临床脑电图有助于发现新生物标志物并追踪疾病进展。
局限性
- 本研究为回顾性设计,样本量有限,模型无法预测癫痫频率,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: EEG plays an integral part in the diagnosis and management of children with genetic epilepsies. Nevertheless, how quantitative EEG features differ between genetic epilepsies and neurologic outcomes remains largely unknown. In this study, we aimed to identify quantitative EEG biomarkers in STXBP1-related, SCN1A-related, and SYNGAP1-related childhood epilepsy and associated neurologic outcomes. METHODS: We retrospectively collected clinical scalp EEGs from the Children's Hospital of Philadelphia. After removing artifacts and epochs with excess noise or altered state from EEGs, we extracted spectral features. We validated our preprocessing pipeline by comparing automatically detected posterior dominant rhythm (PDR) with annotations from clinical EEG reports. Next, as a coarse measure of pathologic slowing, we compared the alpha-delta bandpower ratio between controls and patients with different genetic epilepsies. We then trained random forest models with localized spectral features to predict diagnoses of STXBP1, SCN1A, and SYNGAP1 and estimate seizure frequency and motor function across a broader cohort. RESULTS: We evaluated EEGs from individuals with pathogenic variants in STXBP1 (95 EEGs, n = 20; 40% female; mean age 3.98 years), SCN1A (154 EEGs, n = 68; 51% female; mean age 6.24 years), and SYNGAP1 (46 EEGs, n = 21; 57% female; mean age 6.97 years) and neurotypical controls (847 EEGs, n = 806; 55% female; mean age 7.08 years). There was strong agreement between the automatically calculated PDR and annotations from clinical EEG reports (R2 = 0.75). Individuals with STXBP1-related epilepsy had a significantly lower alpha-delta ratio than controls (median Cohen d = -0.95, p < 0.001) across all ages. Models accurately predicted a diagnosis of STXBP1 (area under the curve [AUC] = 0.92), SYNGAP1 (AUC = 0.86), and SCN1A (AUC = 0.85) against controls and each other (accuracy = 0.74). From these models, we isolated highly correlated biomarkers, including the alpha-theta ratio in frontal, occipital, and parietal electrodes associated with STXBP1, SYNGAP1, and SCN1A, respectively. Models were unable to predict seizure frequency (AUC = 0.53). Models predicted motor scores significantly better than age-based null models (p < 0.001). DISCUSSION: These results suggest that some genetic epilepsies and functional outcome measures have distinct quantitative EEG signatures. Furthermore, EEG spectral features are predictive of some functional outcome measures. Large-scale retrospective quantitative analysis of clinical EEGs has the potential to discover novel biomarkers and to quantify and track individuals' disease progression across development.
引用
- Galer PD, McKee JL, Ruggiero SM, et al. Quantitative EEG Biomarkers in the Genetic Epilepsies and Associations With Neurologic Outcomes. Neurology. 2025. PMID: 40986432. doi:10.1212/WNL.0000000000214148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。